The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project

Abstract

Decision‐making; Non‐small cell lung cancer; Patient knowledge

Toma de decisiones; Cáncer de pulmón de células no pequeñas; Conocimiento del paciente

Presa de decisions; Càncer de pulmó de cèl·lules no petites; Coneixement del pacient

Introduction To date, lung cancer is one of the most lethal diagnoses worldwide. A variety of lung cancer treatments and modalities are available, which are generally presented during the patient and doctor consultation. The implementation of decision tools to facilitate patient's decision-making and the management of their healthcare process during medical consultation is fundamental. Studies have demonstrated that decision tools are helpful to promote health management and decision-making of lung cancer patients during consultations. The main aim of the present work within the I3LUNG project is to systematically review the implementation of decision tools to facilitate medical consultation about oncological treatments for lung cancer patients. Methods In the present study, we conducted a systematic review following the PRISMA guidelines. We used an electronic computer-based search involving three databases, as follows: Embase, PubMed, and Scopus. 10 articles met the inclusion criteria and were included. They explicitly refer to decision tools in the oncological context, with lung cancer patients. Results The discussion highlights the most encouraging results about the positive role of decision aids during medical consultations about oncological treatments, especially regarding anxiety, decision-making, and patient knowledge. However, no one main decision aid tool emerged as essential. Opting for a more recent timeframe to select eligible articles might shed light on the current array of decision aid tools available. Conclusion Future review efforts could utilize alternative search strategies to explore other lung cancer-specific outcomes during medical consultations for treatment decisions and the implementation of decision aid tools. Engaging with experts in the fields of oncology, patient decision-making, or health communication could provide valuable insights and recommendations for relevant literature or research directions that may not be readily accessible through traditional search methods. The development of guidelines for future research were provided with the aim to promote decision aids focused on patients' needs.

The I3LUNG project has received funding from the European Union's Horizon 2020 caLL topic “HORIZON-HLTH-2021-CARE-05-02—Data-driven decision-support tools for better health care delivery and policy-making with a focus on cancer” under grant agreement No 101057695.